Global Cannabidiol (CBD) Testing Market, By Product and Software (Analytical Instruments, Consumables, Software), Testing Procedures (Residual Solvent Screening, Terpene Profiling, Potency Testing, Genetic Testing, Pesticide Screening, Heavy Metal Testing, Microbial Analysis), End-User (Laboratories, Cannabis Cultivators, Research Institutes, Drug Manufacturers, Dispensaries) - Industry Trends and Forecast to 2031.
Cannabidiol (CBD) Testing Market Analysis and Size
Cannabidiol (CBD) testing is expected to witness significant growth during the forecast period due to increasing awareness regarding the benefits of cannabis among consumers along with increasing usage of cannabidiol (CBD) for medical purposes. Also due to a large number of health benefits, the governments in nations are now recognizing the usage of cannabidiol (CBD) for medical purpose. Cannabis is progressively being legalized for medical usage in countries across the globe. The requirement for cannabidiol (CBD) analytical testing is to ensure its safety before consumption, which has developed in recent years.
Data Bridge Market Research analyzes that the global cannabidiol (CBD) testing market, which was USD 48.53 million in 2023, is likely to reach USD 70.62 million by 2031 and is expected to undergo a CAGR of 4.8% during the forecast period of 2024 to 2031. “Analytical Instruments” dominates the product and software segment of the cannabidiol (CBD) testing market due to the constant requirement for precise and efficient testing methodologies.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Product and Software (Analytical Instruments, Consumables, Software), Testing Procedures (Residual Solvent Screening, Terpene Profiling, Potency Testing, Genetic Testing, Pesticide Screening, Heavy Metal Testing, Microbial Analysis), End-User (Laboratories, Cannabis Cultivators, Research Institutes, Drug Manufacturers, Dispensaries)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
CannaSafe (U.S.), Steep Hill, Inc (U.S.), Eirlab Research Group (Ireland), GOODBODY HEALTH INC. (U.S.), CW ANALYTICAL (U.S.), Pure Analytics (U.S.), ANRESCO (U.S.), SC Labs (India), Battelle Memorial Institute (U.S.), Aphria Inc (Canada), Medical Marijuana, Inc (U.S.), STENOCARE A/S (Denmark), Cannabis Science Inc (U.S.), Agilent Technologies, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Cannabidiol (CBD) testing involves analyzing the concentration and purity of CBD, a non-psychoactive compound derived from the cannabis plant. This testing ensures product quality and compliance with regulatory standards. In end uses, CBD testing is crucial for manufacturing reliable CBD-infused products such as oils, tinctures, edibles, and topicals. It verifies potency and identifies any contaminants, providing consumers with safe and accurately labeled products.
In addition, CBD testing supports medical research by confirming the consistency of CBD content in pharmaceuticals. Overall, it plays a pivotal role in ensuring the efficacy, safety, and regulatory compliance of CBD products across various industries.
Cannabidiol (CBD) Testing Market Dynamics
Drivers
- Legalization and regulatory compliance
The increasing legalization of cannabis and CBD products in various regions has surged the demand for standardized testing procedures. Regulatory compliance and quality control drive the need for accurate testing to ensure the safety and potency of CBD products. This requirement stimulates the growth of the CBD testing market, as companies must adhere to stringent regulatory frameworks.
- Rising consumer awareness and demand for quality assurance
With the growing awareness of the potential health benefits of CBD, consumers are becoming more discerning about the quality and safety of the products they purchase. This has led to an increased demand for validated testing to verify the purity, potency, and absence of contaminants in CBD-based products, thereby bolstering the need for reliable testing services.
- Expansion of CBD product varieties
The diversification of CBD products, ranging from oils and tinctures to edibles, topicals, and pharmaceuticals, necessitates comprehensive testing to meet varying quality standards. As the market expands with new product innovations, there's a parallel need for comprehensive testing solutions to ensure consistency and reliability across these diverse product types.
Restraints
- Lack of standardization and regulations
The absence of universally accepted testing protocols and standardized regulations across different regions poses a challenge. Variations in testing methodologies and regulatory frameworks make it challenging for companies to comply with diverse standards, leading to inconsistencies and difficulties in maintaining quality control.
- Cost and time-intensive testing processes
Comprehensive testing processes can be both time and cost-intensive. This poses a restraint for smaller businesses and manufacturers with limited budgets. Balancing the need for extensive testing with cost-effective solutions remains a challenge in the industry, especially for startups and small-scale producers.
Opportunities
- Technological advancements in testing methods
Constant advancements in testing technologies, such as chromatography and spectroscopy, are offering more accurate, efficient, and faster testing methods. These innovations present a significant opportunity for service providers to develop and offer state-of-the-art testing solutions, meeting the increasing demand for precise and quick results.
- Global market expansion and international trade
The globalization of the CBD industry creates an opportunity for testing laboratories and companies to cater to the needs of the international market. With increased cross-border trade and the need for compliance with varying regulatory standards, there is a growing space for testing services to ensure consistency and compliance in CBD products across different regions.
Challenges
- Lack of skilled workforce and expertise
The complex nature of CBD testing requires highly skilled professionals with expertise in various analytical techniques. There's a shortage of qualified personnel well-versed in the nuances of cannabinoid analysis and the sophisticated equipment used in these processes. This scarcity of skilled experts poses a significant challenge for laboratories and companies seeking to maintain high testing standards and limits the scalability of services in the industry.
- Evolving nature of CBD products and contaminant detection
The dynamic nature of CBD products, including the emergence of new delivery methods and formulations, presents a challenge in adapting testing methodologies to detect contaminants. Identifying and understanding the diverse range of potential contaminants in different product types, such as pesticides, heavy metals, and residual solvents, requires continuous research and development of testing methodologies to keep pace with the evolving landscape of CBD product innovation.
This cannabidiol (CBD) testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cannabidiol (CBD) testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Development
- In July 2020, Agilent Technologies recently unveiled pioneering solutions for the surging Global Cannabidiol (CBD) Testing Market, addressing challenges in potency and pesticide/mycotoxin assessments for cannabis and hemp. Launching the Agilent eMethods tool and two kits—Cannabis and Hemp Potency, and Cannabis Pesticide and Mycotoxin—the brand offers a swift setup with step-by-step instructions and consumables for comprehensive analysis. This innovative approach streamlines lab operations, aiding compliance with varying regulations. Monty Benefiel and Angelica Riemann, Agilent VPs, emphasized these solutions' role in establishing efficient testing procedures, enhancing productivity, and minimizing risks
Global Cannabidiol (CBD) Testing Market Scope
The cannabidiol (CBD) testing market is segmented on the basis of product and software, testing procedures, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Software
- Analytical Instruments
- Consumables
- Software
Testing Procedures
- Residual Solvent Screening
- Terpene Profiling
- Potency Testing
- Genetic Testing
- Pesticide Screening
- Heavy Metal Testing
- Microbial Analysis
End-User
- Laboratories
- Cannabis Cultivators
- Research Institutes
- Drug Manufacturers
- Dispensaries
Cannabidiol (CBD) Testing Market Regional Analysis/Insights
The cannabidiol (CBD) testing market is analyzed and market size insights and trends are provided by product and software, testing procedures, and end-user are referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., Israel, Egypt, South Africa, rest of Middle East and Africa, Brazil, Argentina and rest of South America.
North America is expected to dominate the market due to the growing legalization with the increasing usage of cannabis. Moreover, growing number of marijuana cultivators in the region during the forecast period.
North America is also expected to witness the fastest growth during the forecast period due to growing awareness regarding the benefits of cannabis among consumers in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Cannabidiol (CBD) Testing Market Share Analysis
The cannabidiol (CBD) testing market competitive landscape provides details by competitors. details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the cannabidiol (CBD) testing market.
Some of the major players operating in the cannabidiol (CBD) testing market are:
- CannaSafe (U.S.)
- Steep Hill, Inc (U.S.)
- Eirlab Research Group (Ireland)
- GOODBODY HEALTH INC. (U.S.)
- CW ANALYTICAL (U.S.)
- Pure Analytics (U.S.)
- ANRESCO (U.S.)
- SC Labs (India)
- Battelle Memorial Institute (U.S.)
- Aphria Inc (Canada)
- Medical Marijuana, Inc (U.S.)
- STENOCARE A/S (Denmark)
- Cannabis Science Inc (U.S.)
- Agilent Technologies, Inc. (U.S.)
SKU-